![Jason Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Kelly
Grundare på
GINKGO BIOWORKS HOLDINGS, INC.
Förmögenhet: 22 M $ per 2026-05-31
Profil
Jason Kelly is the founder of Ginkgo Bioworks, Inc., founded in 2008, serving as Chief Executive Officer & Director since its founding.
Dr. Kelly is the founder of Ginkgo Bioworks Holdings, Inc., founded in 2008, serving as Chief Executive Officer & Director since its founding.
Dr. Kelly currently serves as Director at Gen9, Inc., Director at Octant, Inc., Director at Motif FoodWorks, Inc., and Venture Partner at NextGen Venture Partners LLC.
Former positions include Chief Executive Officer & Director at Soaring Eagle Acquisition Corp.
and Independent Director at CM Life Sciences II, Inc. in 2021.
Education includes undergraduate and doctorate degrees from the Massachusetts Institute of Technology, conferred in 2003 and 2008 respectively.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-15 | 2 041 437 ( 22,21 % ) | 19 M $ | 2026-05-31 | |
| 2026-04-15 | 316 483 ( 0,59 % ) | 3 M $ | 2026-05-31 |
Aktiva positioner av Jason Kelly
| Företag | Position | Start |
|---|---|---|
| GINKGO BIOWORKS HOLDINGS, INC. | Grundare | 2008-01-01 |
Ginkgo Bioworks, Inc.
 Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Grundare | 2008-01-01 |
Motif Food Works, Inc.
 Motif Food Works, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food ingredients company which provides sustainable alternative proteins and ingredient solutions | Direktör/Styrelseledamot | - |
Octant, Inc.
 Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Direktör/Styrelseledamot | - |
Gen9, Inc.
 Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Direktör/Styrelseledamot | - |
NextGen Venture Partners LLC
 NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Privat kapitalinvesterare | - |
Tidigare kända positioner av Jason Kelly
| Företag | Position | Slut |
|---|---|---|
| STANDARD BIOTOOLS INC. | Direktör/Styrelseledamot | 2021-09-01 |
| GINO BIOW | Verkställande Direktör | - |
Jason Kellys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
15
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Health Technology |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Technology Services |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Finance |
Motif Food Works, Inc.
Motif Food Works, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food ingredients company which provides sustainable alternative proteins and ingredient solutions | Consumer Non-Durables |
CM Life Sciences II, Inc.
 CM Life Sciences II, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Soaring Eagle Acquisition Corp.
 Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ginkgo Bioworks Holdings, Inc.
 Ginkgo Bioworks Holdings, Inc. Medical/Nursing ServicesHealth Services Develops biological engineering products and custom microbes | Health Services |
